Aerospace-Based Healthcare Systems
    1.
    发明公开

    公开(公告)号:US20240358565A1

    公开(公告)日:2024-10-31

    申请号:US18647922

    申请日:2024-04-26

    Abstract: A mobile transportation system, having a plurality of modules, including a self-sufficient hospital facility, small-scale medical device manufacturing facility, vaccine production facility, pharmaceutical production facility, sterilization facility, and food production facility, as well as an accommodation facility; wherein each of said plurality of modules, when necessary can be unloaded from the aerospace object and connected to other modules to become part of a larger modular facility with specific purposes, to allows for customization of the facility depending on the medical or other needs.

    Digital Patient Pathway in personalized healthcare systems with Advanced Medical Manufacturing Simulator

    公开(公告)号:US20240363233A1

    公开(公告)日:2024-10-31

    申请号:US18647896

    申请日:2024-04-26

    CPC classification number: G16H40/20 G16H10/60 G16H50/30

    Abstract: A system and method for generating customized treatments for patients by integrating two AI-driven data systems, herein referred to as Digital Twins. The first Digital Twin encompasses a comprehensive reflection of the patient's health condition, incorporating medical data, genetic information, imaging results, health history, lifestyle factors, and patient-reported complaints. Utilizing this Digital Twin artificial intelligence algorithms, analyzes cross-references between medical conditions and potential treatments to generate digital personalized treatment pathways. Furthermore, it predicts and recommends preventive measures and lifestyle adjustments. The second Digital Twin represents the capabilities of a pharmaceutical manufacturing company or a healthcare enterprise, possessing expertise in producing pharmaceuticals and medical devices. Through AI-driven processes, this Enterprise Digital Twin organizes the production of treatments proposed by the Digital Patient Pathway, ensuring customization and efficiency. This includes but is not limited to manufacturing patient-specific medications, orthopedic implants, or surgical plans.

Patent Agency Ranking